C57BL/6 mice were inoculated with Lewis Lung carcinoma and the treatments as described in Figure 1A . Tumor cells from lung metastasis after treatments were obtained to determine the expression/activation of EGFR (A), p-EGFR (fosfo-EGFR, B), p-Stat3 (fosfo-Stat3, C), NGcGM3 ganglioside (D), uPAR (E), α5β1 integrin (F), Src (G), p-Src (fosfo-Src, H), FAK (I) and p-FAK (fosfo-FAK, J). Dot plots from one animal is representative of each group. One representative experiment out of three performed experiments is shown in each case.
Supplementary Figure 3:
Combinatorial-targeted therapy to EGFR (7A7 mAb) and anti-NGcGM3 (NGcGM3/VSSP vaccine) simultaneously turns off signaling by the EGFR, p-EGFR and pSTAT3 on remaining 3LL-metastases by immunofluorescence. C57BL/6 mice were inoculated with Lewis Lung carcinoma and the treatments as described in Figure 1A . Tumor sections from lung metastases after treatments were fixed with paraformaldehyde to determine the expression/activation of EGFR (A), p-EGFR (fosfo-EGFR, B), p-Stat3 (fosfo-Stat3, C). Data are represented as fluorescence intensity and mean±SD (n=6/group). Statistical analysis was performed using Two-way ANOVA, combined with the Kruskall-Wallis test, for multiples comparison was employed. Statistical differences are indicated: * p<0.05. One representative experiment out of three performed experiments is shown in each case. White bars=100μm.
Supplementary Figure 4:
Combinatorial-targeted therapy to EGFR (7A7 mAb) and anti-NGcGM3 (NGcGM3/ VSSP vaccine) simultaneously turns off signaling by the uPAR/α5β1 integrin on remaining 3LL-metastases by immunofluorescence. C57BL/6 mice were inoculated with Lewis Lung carcinoma and the treatments as described in Figure 1A . Tumor sections from lung metastases after treatments were fixed with paraformaldehyde to determine the expression of NGcGM3 (A), uPAR (B), α5β1 Integrin (C). Data are represented as fluorescence intensity and mean±SD (n=6). Statistical analysis was performed using Two-way ANOVA, combined with the Kruskall-Wallis test, for multiples comparison was employed. Statistical differences are indicated: * p<0.05. One representative experiment out of three performed experiments is shown in each case. White bars=100μm.
Supplementary Figure 5:
Combinatorial-targeted therapy to EGFR (7A7 mAb) and anti-NGcGM3 (NGcGM3/VSSP vaccine) simultaneously inhibits Src and FAK signaling pathways by immunofluorescence assay. C57BL/6 mice were inoculated with Lewis Lung carcinoma and the treatments as described in Figure 1A . Tumor sections from lung metastases after treatments were fixed with paraformaldehyde to determine the expression/activation of Src (A), p-Src (fosfo-Src, B), FAK (C) and p-FAK (fosfo-FAK, D). Data are represented as fluorescence intensity and mean±SD. (n=6/group). Statistical analysis was performed using Two-way ANOVA, combined with the Kruskall-Wallis test, for multiples comparison was employed. Statistical differences are indicated: ***
